Crack Open the Champagne, AiCuris’ Antiviral Launched in Germany
Update (23/02/2018): Merck Sharp & Dohme (MSD), licensee of AiCuris, has launched letermovir in Germany under…
Update (23/02/2018): Merck Sharp & Dohme (MSD), licensee of AiCuris, has launched letermovir in Germany under…
Scientists in London are the first in the world to test how pathogens like the…
ViiV Healthcare has just started a clinical trial to test if its two-drug regimen for…
Researchers may have found a way to stop the female mosquitoes from biting you, which…
Batavia Biosciences joins an international consortium to develop and manufacture a safer type of polio…
Vaccitech has closed a Series A fundraising that will support clinical trials with its vaccine technology…
Researchers have discovered that bacteria break down fruit and vegetables to produce chemicals that control…
Atox Bio develops immune modulators to save patients with severe infections. An oversubscribed Series F financing…
With the recent outbreaks of plague in Madagascar and Ebola in West Africa, two terrifying…
Chikungunya fever could be the next big global outbreak. Reassuringly, Themis' vaccine has so far…
VirionHealth kicks off the development of a broad spectrum antiviral for all influenza strains and other…
A study in Scotland has improved our understanding of how a dangerous parasite functions, creating…